KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $157,079,537 | -11.2% | 928,970 | +13.9% | 0.01% | 0.0% |
Q2 2023 | $176,794,769 | -2.3% | 815,286 | -18.2% | 0.01% | -10.0% |
Q1 2023 | $181,010,617 | -52.8% | 996,535 | -48.9% | 0.01% | -9.1% |
Q4 2022 | $383,441,062 | +94.4% | 1,951,354 | +122.5% | 0.01% | -8.3% |
Q3 2022 | $197,229,000 | +31.2% | 876,845 | -26.2% | 0.01% | +33.3% |
Q2 2022 | $150,349,000 | +15.5% | 1,188,437 | +15.8% | 0.01% | +50.0% |
Q1 2022 | $130,151,000 | +18.4% | 1,026,507 | +22.3% | 0.01% | +20.0% |
Q4 2021 | $109,957,000 | +4.2% | 839,365 | -2.7% | 0.01% | -16.7% |
Q3 2021 | $105,496,000 | +27.4% | 862,389 | +18.8% | 0.01% | +50.0% |
Q2 2021 | $82,778,000 | -2.6% | 726,187 | +2.7% | 0.00% | -20.0% |
Q1 2021 | $85,009,000 | +8.0% | 707,052 | -8.7% | 0.01% | 0.0% |
Q4 2020 | $78,689,000 | +27.3% | 774,579 | -3.1% | 0.01% | +25.0% |
Q3 2020 | $61,828,000 | -27.1% | 799,636 | +5.0% | 0.00% | -33.3% |
Q2 2020 | $84,860,000 | +416.4% | 761,346 | +233.6% | 0.01% | +500.0% |
Q1 2020 | $16,433,000 | +81.4% | 228,235 | +89.8% | 0.00% | 0.0% |
Q4 2019 | $9,061,000 | +819.9% | 120,267 | +99.3% | 0.00% | – |
Q3 2019 | $985,000 | – | 60,330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |